전체 논문 (28편 · 1/1)
-
Adjuvant PD-1 Inhibitors After Radical Surgery for High-Risk Muscle-Invasive Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Phase 3 Trials.
-
Comparative Analysis of Prostate Imaging Reporting and Data System and Prostate Imaging After Focal Ablation Scoring Systems in the Postfocal Therapy Assessment of Clinically Significant Prostate Cancer.
-
Disparities in Prostate Cancer-Specific Mortality in Incarcerated vs Nonincarcerated Patients in Michigan: A Statewide Retrospective Cohort Study.
-
Risk Factors for Fluoroquinolone Resistance on Preprostate Biopsy Rectal Swab.
-
The Impact of Medicaid Expansion on Insurance Coverage and Metastatic Disease at Diagnosis for Racial and Ethnic Subgroups Diagnosed with Prostate Cancer.
-
Factors Associated With Early Detection of Clinically Significant Prostate Cancer After a Negative Magnetic Resonance Imaging-Informed Biopsy.
-
Enhancing Prostate Cancer Screening Literacy Through Shared Decision-Making: Results of a Randomized Trial in a Vulnerable Population.
-
Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized Prostate Cancer in a North American Statewide Cohort.
-
Association Between Perirectal Spacer Use and Short-Term Complications After Prostate Radiation Therapy in a National Claims-Based Analysis.
-
Real-world experience with PSMA-PET in primary staging and biochemical recurrence settings: data from the Michigan Urological Surgery Improvement Collaborative.
-
Utilization of Prediagnostic Prostate Magnetic Resonance Imaging Among Rural Americans: An Analysis of Medicare Claims for Elevated Prostate-Specific Antigen.
-
Utility of F-Flotufolastat Positron Emission Tomography/Computed Tomography Imaging in High-Risk Prostate Cancer in a Real-World Setting.
-
Does the Veterans Affairs Risk Analysis Index Overestimate Frailty in Patients With Localized Prostate Cancer?
-
Letter: Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.
-
First-Line Anti-PD-1 Immunotherapy With Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis by PD-1 Subtype.
-
Practice Trends in OnabotulinumtoxinA and Augmentation Cystoplasty: Implications for Adult and Pediatric Urology.
-
Trends in Utilization of Sacral Neuromodulation for Overactive Bladder: Insight From the AUA AQUA Registry.
-
The Impact of Telehealth on Treatment Decision-Making in Prostate Cancer.
-
Rural-Urban Differences and Socioeconomic Disparities in Long-Term Urinary Adverse Events Following Prostate Cancer Treatment.
-
Opportunities for Quality Improvement in Postoperative Prostate-Specific Antigen Testing After Radical Prostatectomy.
-
Use of Doublet or Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer Across Community-Based Urology Settings in the United States.
-
Penile Prosthesis Implantation After Radical Prostatectomy in the United States.
-
Cryotherapy and High-Intensity Focused Ultrasound: National Utilization Trends (2016-2022).
-
Differences in the Use and Quality of Active Surveillance for Prostate Cancer Among Men Insured by Medicaid.
-
Adverse Cardiovascular Outcomes of Individuals Treated With Androgen Deprivation Therapy.
-
Robot-Assisted Radical Prostatectomy: The Impact of Patient Positioning and Surgical Access on Intraoperative Anesthesiologic Parameters.
-
Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population.
-
Review of New Implantable Tibial Nerve Stimulators in Comparison to Established Third Line Treatment Modalities for Nonneurogenic Overactive Bladder.